News

Linkers Industries Limited Schedules Initial IPO for Nasdaq Launch

Linkers Industries Limited Schedules Initial IPO for Nasdaq Launch

Linkers Industries Limited Commences Initial Public Offering

Linkers Industries Limited (Nasdaq: LNKS), a prominent manufacturer and supplier of wire and cable harnesses, has officially announced the pricing of its initial public offering (IPO). This exciting development follows a well-organized plan aimed at expanding its operations and reach within the industry.

Details of the IPO

The company has priced its IPO at $4.00 per Class A ordinary share, with a total of 1,900,000 shares being made available to the public. Trading is anticipated to commence shortly, signaling a pivotal moment for the company and its stakeholders, as it joins the ranks of publicly traded entities on the Nasdaq Capital Market.

Expected Closing and Use of Proceeds

Investors can expect the offering to finalize tomorrow, pending the fulfillment of standard closing conditions. The funds raised from this IPO are intended for several strategic initiatives. Linkers Industries plans to acquire businesses or form joint ventures in the value chain of wire and cable harnesses. Additionally, the capital will facilitate the purchase of new machinery, bolster marketing efforts, and establish global sales offices, with a keen focus on expanding its presence in the U.S. market.

Underwriting and Legal Counsel

The underwriting of this offering is being executed on a firm commitment basis. R. F. Lafferty & Co., Inc. leads the underwriting efforts, supported by Revere Securities LLC as co-underwriter. This strong team of underwriters will play a key role in managing the offering process efficiently.

Legal Representation

To ensure a smooth procedure, Loeb & Loeb LLP serves as the U.S. legal counsel for Linkers Industries, while VCL Law LLP provides legal support for the underwriters involved in the offering.

Regulatory Compliance and Prospectus Availability

The IPO has been registered with the U.S. Securities and Exchange Commission (SEC), following the approval of the company’s registration statement. Prospective investors are encouraged to review the prospectus, which contains vital information regarding the offering and the company's operations.

Company Overview

Linkers Industries Limited boasts over two decades of experience in manufacturing and supplying wire and cable harnesses. With its production facilities located in Malaysia, the company serves renowned global brand name manufacturers and original equipment manufacturers (OEMs) in various sectors such as home appliances, industrial products, and automotive industries. Their commitment to customized solutions has garnered a strong reputation among customers throughout the Asia Pacific region.

Commitment to Innovation

As Linkers Industries prepares for its IPO, the company remains dedicated to innovation and quality in its products. By leveraging advanced technology and skilled craftsmanship, they aim to maintain and enhance their competitive edge in the wire and cable harness market.

Frequently Asked Questions

What is the stock ticker for Linkers Industries Limited?

Linkers Industries Limited trades under the stock ticker LNKS on the Nasdaq.

When is Linkers Industries Limited expected to start trading publicly?

Linkers Industries Limited is anticipated to begin trading on the Nasdaq Capital Market shortly after the closing of its initial public offering.

How many shares are being offered in the IPO?

The company is offering a total of 1,900,000 Class A ordinary shares in its initial public offering.

What will the proceeds from the IPO be used for?

The proceeds will fund acquisitions, joint ventures, machinery purchases, marketing initiatives, and working capital requirements.

Who are the underwriters for this offering?

The underwriters for the offering include R. F. Lafferty & Co., Inc. and Revere Securities LLC.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Fosun Pharma Hits the Buyback Button: What's Next?

Updated Category News Views 0

Fosun Pharma's Bold Move Well, if this isn't Fosun Pharma making some noise! Announcing an H-share repurchase plan worth up to HK$1 billion is like setting off fireworks amidst any investor's evening. They're hollering to the market, 'We see value, and we're doubling down on it.' Crunching the Numbers In the first half of 2026, Fosun Pharma's numbers weren't just a flash...

Continue Reading
Harbour BioMed Joins Stock Connect, Boosts Investor Access

Updated Category News Views 1

The Big Leap: Harbour BioMed Joins Stock Connect Well, if this ain't something to get excited about—Harbour BioMed just snagged a spot on the Stock Connect roster. This step isn't just ceremonial. We're talking about real access for mainland Chinese investors to dive directly into the shares of Harbour BioMed (HKEX: 02142.HK) through the Shanghai-Hong Kong and...

Continue Reading
Bad Bunny Super Bowl Halftime Show Sweeps 7 Emmy Wins

Updated Category News Views 3

An Unprecedented Performance: A Halftime Show for the Ages Hold onto your hats, folks—Bad Bunny and his Super Bowl LX Halftime Show have taken home a jaw-dropping seven Emmys at the 78th Emmy Awards. This is uncharted territory for any Super Bowl Halftime Show. Never before has a halftime spectacle swept the Emmys like this. We’re talking about categories such as...

Continue Reading
Asia-Pacific Media Forum Eyes Future Growth Strategies

Updated Category News Views 2

Media Heavyweights Converge in Shenzhen Picture this: Over 400 media moguls from the Asia-Pacific region, huddled together in Shenzhen under that blazing September sun. What for? They're on a mission, inspecting China's shifting landscape, hunting down fresh growth avenues in the Guangdong-Hong Kong-Macao Greater Bay Area. It kicks off within the walls of the Asia-Pacific...

Continue Reading
Aroa Biosurgery Reports Low Infection Rates: A Milestone

Updated Category News Views 1

Peer-Reviewed Study: Aroa's Myriad Shows Low Infection Rates Seems like the folks at Aroa Biosurgery have got something solid to brag about in the world of complex soft tissue reconstruction. The company just released interim results from their massive MASTRR Registry study, and the numbers are looking pretty darn promising. We're talking about a 411-patient analysis...

Continue Reading
EyePoint Stumbles: Legal Eagles Circle Post-Trial Flop

Updated Category News Views 2

EyePoint Slips on Clinical Banana Peel Well, if EyePoint was aiming for a splash, they sure got it—just not the kind they were hoping for. News dropped like a lead balloon when EyePoint announced their Phase 3 DURAVYU trial results for wet age-related macular degeneration, revealing they missed their primary endpoint. And what did that mean for their stock? A death...

Continue Reading
Mermaid Folklore Meets Revolution in New Short Film

Updated Category News Views 2

A Sea Haunting Like No Other Ever feel like history's forgotten tales deserve a fresh spin? Well, this one's shaking it up! Hoyt Dwyer, an Atlanta filmmaker, flips the script on a lesser-known bit from the American Revolution. Yeah, we're talking about Hessian soldiers and sirens here. Just hang on to your hats because this ain't your typical historical retelling. A...

Continue Reading
Creality Rolls Out K3, SPARKX i8 at IFA 2026

Updated Category News Views 12

Creality Struts Its Stuff at IFA 2026 You wouldn't guess 3D printing had anything left to dazzle us with, but Creality has sure put those notions to rest at the IFA 2026 in Berlin. They're rolling out the big guns with fresh tech that pushes both efficiency and sustainability—two big buzzwords these days—and ties a neat little bow on their innovative streak....

Continue Reading
Ice-Rock Avalanches: Future Risks and Urgent Lessons

Updated Category News Views 1

Mounting Threats in Mountain Chains That nightmare on August 26 at Mount Langtang Lirung in Nepal—where an ice-rock avalanche triggered a catastrophic mudslide—brought a harsh reminder that these mountains are cracking wide open. With 31 dead and over 500 souls still unaccounted for, it's a chilling warning about how vulnerable high-altitude regions have become. A...

Continue Reading

Top 5 Most Recently Viewed Articles

Aterian Prepares for Upcoming Earnings Call This Quarter

Updated Category News Views 99

Aterian's Upcoming Financial Results Announcement Aterian, Inc. (Nasdaq: ATER), a prominent player in the consumer products sector, is gearing up to reveal its financial performance for the second quarter. Scheduled for Wednesday in the coming week, this announcement will take place after market closure, providing investors with valuable insights into the company’s...

Continue Reading
Analyzing RTX: Trends in Short Interest and Market Sentiment

Updated Category News Views 176

Understanding RTX's Recent Market Movements RTX Corp has seen a notable shift in its market dynamics recently. The company's short interest, defined as the number of shares sold short but not yet covered, has decreased by 7.63% since the last reporting period. Currently, there are approximately 16.18 million shares sold short, equating to 1.21% of all shares available for...

Continue Reading
Celebrate Christmas Spirit with Personalized PrayerSongs

Updated Category News Views 156

Celebrate the Joy of Christmas with PrayerSong Bring Love Into Your Home with a PrayerSong for Your Family and Friends When the holiday season arrives, the focus shifts beyond material gifts. Instead, it’s about nurturing connections filled with love, faith, and meaningful moments. This Christmas, PrayerSong provides families with a unique opportunity to honor loved...

Continue Reading
Understanding the Short Selling Landscape of Analog Devices

Updated Category News Views 153

Analyzing Short Interest for Analog Devices As investors navigate the ever-changing stock market, understanding short interest can provide valuable insights into market sentiment regarding Analog Devices (NYSE: ADI). Recently, it was reported that Analog Devices has seen a notable increase of 4.11% in its short percent of float. Currently, there are approximately 7.52...

Continue Reading
Future of Clinical Trials: Exploring Market Growth to USD 85.37 Billion

Updated Category News Views 71

Understanding Clinical Trials and Their Importance Clinical trials serve as a fundamental pillar in advancing medical knowledge and enhancing patient care. These trials encompass a detailed and thorough process involving participant recruitment, intervention administration, data collection, and result analysis. The outcomes produced from clinical trials play a crucial...

Continue Reading